Leishmaniasis: Clinical Trials

1 trial for Leishmaniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Leishmaniasis: new trials by email Literature Review of Leishmaniasis trials Research Report on Leishmaniasis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Antimoniate of N-methylglucamine, amphotericin B deoxycholate, Liposomal amphotericin B - Visceral Leishmaniasis
Phase 4TerminatedUniversity of Brasilia3782011-02-012017-09-05

Narrower conditions

Leishmaniasis, Visceral (1)

Broader conditions

Euglenozoa Infections (1)  ·  Infections (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Vector Borne Diseases (1)

Interventions

Amphotericin B (1)  ·  Meglumine Antimoniate (1)  ·  amphotericin B, deoxycholate drug combination (1)  ·  liposomal amphotericin B (1)

Sponsors

University of Brasilia (1)

Countries

Brazil (1)

Top investigators

Ana LT Rabello, MD PhD (1)  ·  Andrea L de Carvalho, MD (1)  ·  Carlos HN Costa, MD PhD (1)  ·  Dorcas L Costa, MD PhD (1)  ·  Fabiana P Alves, MD PhD (1)  ·  Gustavo AS Romero, MD PhD (1)  ·  Roque P de Almeida, MD PhD (1)  ·  Silvio FG de Carvalho, MD PhD (1)

Results publications

PMID 28662034